Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Saito K, Orimo K, Kubo T, Tamari M, Yamada A, Motomura K, Sugiyama H, Matsuoka R, Nagano N, Hayashi Y, et al
Retatrutide Research# The pivotal Phase 2 trial (338 participants, NEJM 2023) showed 24.2% weight loss at 48 weeks
The results are variable according to skin tone from darker to lighter
Retatrutide dosage chart compared to other weight loss peptides Understanding how retatrutide dosing compares to semaglutide and tirzepatide helps researchers contextualize their protocol and understand where retatrutide fits in the landscape of incretin-based peptides
Check Cold-Chain Integrity: Semaglutide is a delicate peptide
